Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > LATEST
LATEST
-
BUSINESS Otsuka’s Centanafadine Meets PIII Goal in ADHD Patients with Anxiety
June 26, 2026
-
BUSINESS Shionogi Welcomes Government Roadmap’s Focus on Infectious Diseases
June 26, 2026
-
COLUMN The Psychology of ‘Stuck’: Understanding Why Changing Jobs Feels So Hard
June 26, 2026
-
BUSINESS Sawai Cleared to Manufacture Nichi-Iko’s Lipitor Generic
June 26, 2026
-
BUSINESS Jardiance Tops Five Promotion Channels in May: Intage
June 26, 2026
-
REGULATORY Japan Targets Global-Level Growth for Domestic Patented Drug Market
June 25, 2026
-
ORGANIZATION Industry Hails Japan Growth Roadmap, PhRMA Urges Follow-Through
June 25, 2026
-
REGULATORY Paxlovid, Awiqli Braced for NHI Price Cuts after CEAs
June 25, 2026
-
REGULATORY Drug Pricing to Be Applied to Oncolys Oncolytic Virus Therapy
June 25, 2026
-
REGULATORY Japan Diet Begins Deliberations on Immunization Act Revision
June 25, 2026
-
BUSINESS Tanabe Starts Long-Term Uplizna Study in IgG4-Related Disease
June 25, 2026
-
BUSINESS ASKA Shareholders Back Faster Poison Pill Activation
June 25, 2026
-
REGULATORY Expert Calls for AMR Ecosystem to Boost Japan Antibiotic Innovation
June 25, 2026
-
REGULATORY PMDA Eyes AI as Staffing Shortages Affect Orphan Drug Reviews
June 25, 2026
-
BUSINESS EU Approves Padcev-Keytruda for Earlier Bladder Cancer Use
June 25, 2026
-
BUSINESS Tacrolimus Generics Add Cell Transplantation Indication
June 25, 2026
-
BUSINESS Takeda Hands CEO Baton to Kim after 12-Year Weber Era
June 24, 2026
-
REGULATORY US Opens Probe into German Drug Pricing Policies; Could Japan Be Next?
June 24, 2026
-
BUSINESS Regenxbio Clears Path to Resubmit Hunter Syndrome Gene Therapy
June 24, 2026
-
BUSINESS Merck Biopharma Files Lurbinectedin for SCLC in Japan
June 24, 2026
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…